Humana (HUM) Teams Up with Vori Health and HOPCo to Enhance Patient Outcomes

Humana Inc. (NYSE:HUM) ranks among the best performing S&P 500 stocks in the last 3 months. In a bid to improve care for Medicare Advantage members with musculoskeletal conditions, Humana Inc. (NYSE:HUM) announced new value-based care agreements with Vori Health and HOPCo on August 27.

Valeri Potapova/Shutterstock.com

Through these collaborations, qualified Humana Medicare Advantage members will have access to care coordination teams that collaborate with their primary care physicians. These agreements also expand Humana’s established musculoskeletal care program, which comprises a partnership with TailorCare to serve Medicare Advantage members in Atlanta.

Humana Inc. (NYSE:HUM) is focused on improving health and well-being by providing a variety of healthcare benefits to its medical and specialty members. These include fully insured medical and specialty health insurance that covers vision, dental, and supplemental health benefits, as well as administrative services only (ASO) packages for individuals and employers.

While we acknowledge the potential of HUM to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HUM and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.